Karasawa K, Qiu X, Lee T
Biochemistry, Basic and Applied Research Unit, Oak Ridge Associated Universities, Oak Ridge, Tennessee 37831-0117, USA.
J Biol Chem. 1999 Mar 26;274(13):8655-61. doi: 10.1074/jbc.274.13.8655.
We have previously identified two enzyme activities that transfer the acetyl group from platelet-activating factor (PAF) in a CoA-independent manner to lysoplasmalogen or sphingosine in HL-60 cells, endothelial cells, and a variety of rat tissues. These were termed as PAF:lysoplasmalogen (lysophospholipid) transacetylase and PAF:sphingosine transacetylase, respectively. In the present study, we have solubilized and purified this PAF-dependent transacetylase 13,700-fold from rat kidney membranes (mitochondrial plus microsomal membranes) based on the PAF:lysoplasmalogen transacetylase activity. The mitochondria and microsomes were prepared and washed three times, then solubilized with 0.04% Tween 20 at a detergent/protein (w/w) ratio of 0.1. The solubilized fractions from mitochondria and microsomes were combined and subjected to sequential column chromatographies on DEAE-Sepharose, hydroxyapatite, phenyl-Sepharose, and chromatofocusing. The enzyme was further purified by native-polyacrylamide gel electrophoresis (PAGE) and affinity gel matrix in which the competitive inhibitor of the enzyme, 1-O-hexadecyl-2-N-methylcarbamyl-sn-glycero-3-phosphoethanolamine was covalently attached to the CH-Sepharose. On SDS-PAGE, the purified enzyme showed a single homogeneous band with an apparent molecular mass of 40 kDa. The purified enzyme catalyzed transacetylation of the acetyl group not only from PAF to lysoplasmalogen forming plasmalogen analogs of PAF, but also to sphingosine producing N-acetylsphingosine (C2-ceramide). In addition, this enzyme acted as a PAF-acetylhydrolase in the absence of lipid acceptor molecules. These results suggest that PAF-dependent transacetylase is an enzyme that modifies the cellular functions of PAF through generation of other diverse lipid mediators.
我们之前已经鉴定出两种酶活性,它们能以不依赖辅酶A的方式将血小板活化因子(PAF)中的乙酰基转移至HL-60细胞、内皮细胞及多种大鼠组织中的溶血缩醛磷脂或鞘氨醇。这两种酶分别被称为PAF:溶血缩醛磷脂(溶血磷脂)转乙酰酶和PAF:鞘氨醇转乙酰酶。在本研究中,我们基于PAF:溶血缩醛磷脂转乙酰酶活性,从大鼠肾膜(线粒体加微粒体膜)中溶解并纯化了这种PAF依赖性转乙酰酶,纯化倍数达13700倍。制备线粒体和微粒体并洗涤三次,然后用0.04%吐温20以去污剂/蛋白质(w/w)比例0.1进行溶解。将线粒体和微粒体的溶解组分合并,并在DEAE-琼脂糖、羟基磷灰石、苯基-琼脂糖上进行连续柱色谱,以及进行聚焦层析。通过天然聚丙烯酰胺凝胶电泳(PAGE)和亲和凝胶基质进一步纯化该酶,在亲和凝胶基质中,该酶的竞争性抑制剂1-O-十六烷基-2-N-甲基氨基甲酰基-sn-甘油-3-磷酸乙醇胺共价连接到CH-琼脂糖上。在SDS-PAGE上,纯化后的酶呈现出一条单一的均一性条带,表观分子量为40 kDa。纯化后的酶不仅催化乙酰基从PAF转移至溶血缩醛磷脂,形成PAF的缩醛磷脂类似物,还催化乙酰基转移至鞘氨醇生成N-乙酰鞘氨醇(C2-神经酰胺)。此外,在没有脂质受体分子的情况下,这种酶还可作为PAF-乙酰水解酶发挥作用。这些结果表明,PAF依赖性转乙酰酶是一种通过生成其他多种脂质介质来改变PAF细胞功能的酶。